The haemostatic role of tissue factor pathway inhibitor
Review published in Arteriosclerosis, thrombosis, and vascular biology (2007)
Abstract
Under normal conditions the blood circulates freely within the confines of the vascular system, carrying oxygen, nutrients, and hormonal information around the body and removing metabolic waste. If blood gains access to extravascular sites, or the vasculature becomes pathologically challenged, hemostasis may be activated. This process is finely regulated by positive and negative feedback loops that modulate fibrin clot formation. Blood coagulation revolves around the activation and assembly of the components of the prothrombinase complex, which converts the inactive zymogen, prothrombin, into its active form, thrombin. This serine protease catalyzes the conversion of fibrinogen to fibrin, the structural scaffold that stabilizes platelet aggregates at sites of vascular injury. The extent of the hemostatic response is controlled by the action of inhibitory pathways, which ensure that thrombin activity and the spread of the hemostatic plug is limited to the site of vessel damage. This review article focuses on the major physiological regulator of tissue factor-induced coagulation, tissue factor pathway inhibitor, its expression, anticoagulant function, and its role in normal hemostasis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
This review explains how blood coagulation activates thrombin to form fibrin clots at injury sites, regulated by inhibitory feedback pathways, then focuses on tissue factor pathway inhibitor, the principal regulator of tissue factor-triggered coagulation, covering its expression, anticoagulant action and role in hemostasis.
Context
This review article examines the physiological role of tissue factor pathway inhibitor (TFPI) in regulating tissue factor-induced coagulation and maintaining hemostatic balance. It describes how TFPI modulates thrombin generation and limits clot propagation to sites of vascular injury. The article provides background on endogenous anticoagulant pathways that parallel some mechanisms of leech-derived anticoagulants such as hirudin, offering context for understanding the broader coagulation cascade that leech secretome components interact with. CAVEAT: This review contains no direct discussion of leeches, hirudin, hirudotherapy, or any leech-derived compounds; its relevance is strictly indirect as general coagulation biology background.
Citation
Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026